These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 21971557)
1. Antioxidant treatment may protect pancreatic beta cells through the attenuation of islet fibrosis in an animal model of type 2 diabetes. Lee E; Ryu GR; Ko SH; Ahn YB; Yoon KH; Ha H; Song KH Biochem Biophys Res Commun; 2011 Oct; 414(2):397-402. PubMed ID: 21971557 [TBL] [Abstract][Full Text] [Related]
2. A role of pancreatic stellate cells in islet fibrosis and β-cell dysfunction in type 2 diabetes mellitus. Lee E; Ryu GR; Ko SH; Ahn YB; Song KH Biochem Biophys Res Commun; 2017 Apr; 485(2):328-334. PubMed ID: 28232184 [TBL] [Abstract][Full Text] [Related]
3. Rare sugar D-psicose protects pancreas β-islets and thus improves insulin resistance in OLETF rats. Hossain A; Yamaguchi F; Matsunaga T; Hirata Y; Kamitori K; Dong Y; Sui L; Tsukamoto I; Ueno M; Tokuda M Biochem Biophys Res Commun; 2012 Sep; 425(4):717-23. PubMed ID: 22877751 [TBL] [Abstract][Full Text] [Related]
4. Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase. Huang Q; Bu S; Yu Y; Guo Z; Ghatnekar G; Bu M; Yang L; Lu B; Feng Z; Liu S; Wang F Endocrinology; 2007 Jan; 148(1):81-91. PubMed ID: 17053028 [TBL] [Abstract][Full Text] [Related]
6. The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats. Fukaya N; Mochizuki K; Tanaka Y; Kumazawa T; Jiuxin Z; Fuchigami M; Goda T Eur J Pharmacol; 2009 Dec; 624(1-3):51-7. PubMed ID: 19818342 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress plays a role in high glucose-induced activation of pancreatic stellate cells. Ryu GR; Lee E; Chun HJ; Yoon KH; Ko SH; Ahn YB; Song KH Biochem Biophys Res Commun; 2013 Sep; 439(2):258-63. PubMed ID: 23973482 [TBL] [Abstract][Full Text] [Related]
8. Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes. Kim KS; Oh DH; Kim JY; Lee BG; You JS; Chang KJ; Chung HJ; Yoo MC; Yang HI; Kang JH; Hwang YC; Ahn KJ; Chung HY; Jeong IK Exp Mol Med; 2012 Nov; 44(11):665-73. PubMed ID: 23114424 [TBL] [Abstract][Full Text] [Related]
9. Treatment with atorvastatin attenuates progression of insulin resistance and pancreatic fibrosis in the Otsuka Long-Evans Tokushima fatty rats. Wei L; Yamamoto M; Harada M; Otsuki M Metabolism; 2016 Feb; 65(2):41-53. PubMed ID: 26773928 [TBL] [Abstract][Full Text] [Related]
10. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats. Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491 [TBL] [Abstract][Full Text] [Related]
11. Olmesartan and temocapril prevented the development of hyperglycemia and the deterioration of pancreatic islet morphology in Otsuka-Long-Evans-Tokushima Fatty rats. Kaihara M; Nakamura Y; Sugimoto T; Uchida HA; Norii H; Norii H; Hanayama Y; Makino H Acta Med Okayama; 2009 Feb; 63(1):35-42. PubMed ID: 19247421 [TBL] [Abstract][Full Text] [Related]
12. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753 [TBL] [Abstract][Full Text] [Related]
13. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Nakaya Y; Minami A; Harada N; Sakamoto S; Niwa Y; Ohnaka M Am J Clin Nutr; 2000 Jan; 71(1):54-8. PubMed ID: 10617946 [TBL] [Abstract][Full Text] [Related]
14. A traditional Chinese medicine JiuHuangLian (Rhizoma coptidis steamed with rice wine) reduces oxidative stress injury in type 2 diabetic rats. Li JC; Shen XF; Meng XL Food Chem Toxicol; 2013 Sep; 59():222-9. PubMed ID: 23791751 [TBL] [Abstract][Full Text] [Related]
15. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats. Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763 [TBL] [Abstract][Full Text] [Related]
16. Apigenin attenuates streptozotocin-induced pancreatic β cell damage by its protective effects on cellular antioxidant defense. Wang N; Yi WJ; Tan L; Zhang JH; Xu J; Chen Y; Qin M; Yu S; Guan J; Zhang R In Vitro Cell Dev Biol Anim; 2017 Jun; 53(6):554-563. PubMed ID: 28181104 [TBL] [Abstract][Full Text] [Related]
17. Compound K protects pancreatic islet cells against apoptosis through inhibition of the AMPK/JNK pathway in type 2 diabetic mice and in MIN6 β-cells. Guan FY; Gu J; Li W; Zhang M; Ji Y; Li J; Chen L; Hatch GM Life Sci; 2014 Jun; 107(1-2):42-9. PubMed ID: 24802125 [TBL] [Abstract][Full Text] [Related]
18. Liraglutide protects pancreatic beta cells during an early intervention in Gato-Kakizaki rats. Luo X; Pan L; Nie A; Wang Q; Gu Y; Li F; Zhang H; Li W; Li X J Diabetes; 2013 Dec; 5(4):421-8. PubMed ID: 23590680 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of Hachimi-jio-gan against the development of pancreatic fibrosis and oxidative damage in Otsuka Long-Evans Tokushima Fatty rats. Yamabe N; Yokozawa T J Ethnopharmacol; 2007 Aug; 113(1):91-9. PubMed ID: 17606344 [TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone inhibits early stage of glucolipotoxicity-induced beta-cell apoptosis. Han SJ; Kang ES; Hur KY; Kim HJ; Kim SH; Yun CO; Choi SE; Ahn CW; Cha BS; Kang Y; Lee HC Horm Res; 2008; 70(3):165-73. PubMed ID: 18663317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]